MannKind Corporation ( MNKD) - Stock Earnings
MNKD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
MNKD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -15.9 million USD | 112.0 million USD |
| 2026Q1 | -16.6 million USD | 90.2 million USD |
| 2026Q2 | -19.0 million USD | 109.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MNKD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.9 million USD | 199.0 million USD |
| 2024 | 27.6 million USD | 285.5 million USD |
| 2025 | 5.9 million USD | 349.0 million USD |
| 2026 Est. | — | — |
MNKD
Price: $3.19
52 week price:
Earnings Per Share: -0.15 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -28.5 millionMarket Capitalization: 1.2 billion